R Squared’s Integra LifeSciences IART Stock Holding History

R Squared’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-320	Closed	-$7.26K	–	839
2024 Q4	$7.26K	Buy	+320	New	+$6.99K	0.01%	1235

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

R Squared's IART Position: Q1 2025 in Review

R Squared sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 320 shares — an estimated $7.26K sold.

R Squared first reported a position in IART in Q4 2024 and held it in 1 quarter. The position peaked at $7.26K in Q4 2024. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

R Squared reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
R Squared sold 320 Integra LifeSciences shares in Q1 2025, an estimated $7.26K.
R Squared first reported a position in Integra LifeSciences in Q4 2024 and held it in 1 quarter.
R Squared's Integra LifeSciences position peaked at $7.26K in Q4 2024.
219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.